Abstract
Background
Resting heart rate (RHR), has been related to increased risk of dementia, but the relationship between RHR and brain age is unclear.
Objective
We aimed to investigate the association of RHR with brain age and brain age gap (BAG, the difference between predicted brain age and chronological age) assessed by multimodal Magnetic Resonance Imaging (MRI) in mid- and old-aged adults.
Design
A longitudinal study from the UK Biobank neuroimaging project where participants underwent brain MRI scans 9+ years after baseline.
Setting
A population-based study.
Participants
A total of 33,381 individuals (mean age 54.74 ± 7.49 years; 53.44% female).
Measurements
Baseline RHR was assessed by blood pressure monitor and categorized as <60, 60–69 (reference), 70–79, or ≥80 beats per minute (bpm). Brain age was predicted using LASSO through 1,079 phenotypes in six MRI modalities (including T1-weighted MRI, T2-FLAIR, T2*, diffusion-MRI, task fMRI, and resting-state fMRI). Data were analyzed using linear regression models.
Results
As a continuous variable, higher RHR was associated with older brain age (β for per 1-SD increase: 0.331, 95% [95% confidence interval, CI]: 0.265, 0.398) and larger BAG (β: 0.263, 95% CI: 0.202, 0.324). As a categorical variable, RHR 70–79 bpm and RHR ≥80 bpm were associated with older brain age (β [95% CI]: 0.361 [0.196, 0.526] / 0.737 [0.517, 0.957]) and larger BAG (0.256 [0.105, 0.407] / 0.638 [0.436, 0.839]), but RHR< 60 bpm with younger brain age (−0.324 [−0.500, −0.147]) and smaller BAG (−0.230 [−0.392, −0.067]), compared to the reference group. These associations between elevated RHR and brain age were similar in both middle-aged (<60) and older (≥60) adults, whereas the association of RHR< 60 bpm with younger brain age and larger BAG was only significant among middle-aged adults. In stratification analysis, the association between RHR ≥80 bpm and older brain age was present in people with and without CVDs, while the relation of RHR 70–79 bpm to brain age present only in people with CVD.
Conclusion
Higher RHR (>80 bpm) is associated with older brain age, even among middle-aged adults, but RHR< 60 bpm is associated with younger brain age. Greater RHR could be an indicator for accelerated brain aging.
Key words: Resting heart rate, brain age, magnetic resonance imaging, UK Biobank
Introduction
Resting heart rate (RHR) is used to describe the frequency of the cardiac cycle, which is a major determinant of cardiovascular performance and an indicator of autonomic nervous system activity and metabolic rate (1, 2). During the aging process, abnormal changes in RHR may occur due to decreased cardiovascular fitness and autonomic tone or sinus node dysfunction (2, 3, 4). An elevated RHR has been linked to an increased risk of mortality and morbidity among older adults (1, 5), as well as faster cognitive decline and a higher risk of dementia (6, 7, 8, 9, 10, 11).
Brain magnetic resonance imaging (MRI) is an important tool for understanding brain health, offering an opportunity to evaluate the possible mechanisms underlying brain aging (12, 13). Several studies have investigated the association of elevated RHR with structural or functional brain MRI measures, with inconsistent findings (7, 8, 14, 15, 16, 17, 18). Meanwhile, machine learning methods based on multimodal MRI measurements provide the possibility to assess age-related changes in the brain in a more comprehensive manner (19). For example, predicted brain age combines several individual MRI measures (regional brain volume, cortical thickness, fractional anisotropy, functional connection, etc.).
In contrast to individual MRI measures, predicted brain age integrates information on multiple MRI measures into a single metric, factoring in the complex patterns of subtle brain structural changes and the interactions between different brain regions, thus yielding a more sensitive measure of brain aging (20). The difference between predicted brain age and an individual's actual chronological age, the brain age gap (BAG), is thought to reflect neuroanatomical abnormalities and may be a marker of overall brain health (21). To date, no studies have addressed the association between RHR and brain age in middle-aged and older adults, and it is unclear whether the RHR-brain age relationship varies according to cardiovascular disease (CVD) status.
In the present study, using data from middle-aged (<60) and older (≥60) adults in the UK Biobank, we aimed to: (1) assess the association of RHR with brain age and BAG and (2) explore the role of CVD in these associations.
Methods
Study design and population
This study used data from the UK Biobank, a large-scale population-based cohort of 502,412 UK residents aged from 37 to 73 years (22). The UK Biobank study received ethical approval from the National Health Services (NHS) National Research Ethics Service (Ref 11/NW/0382) and all enrolled participants provided informed and written consent.
The baseline survey started in 2006 and a sub-sample of 42,806 participants underwent MRI assessment beginning in 2014. Of them, 34,296 participants with complete brain MRI data were included in the brain age construct. Then, three subsets were defined, including a training set (for training the brain age model, n= 3,484), a validation set (for validating model performance, n= 871), and a testing set (n= 29,941). The training and validation data (in a ratio of 8:2) included people who met health criteria at the time of the scan (n= 4,355), thus excluding people with an ICD-10 diagnosis (field ID 41270), self-reported long-term illness disability or frailty (field ID 2188), diabetes (field ID 2443), history of stroke (field ID 4056), and self-reported fair or poor health status (field ID 2178).
After further excluding 915 participants with prevalent chronic brain disorders (n=864; Table S1), missing information on RHR (n=17), and RHR <40 (n=35), 33,381 participants were included in the RHR-brain aging analysis (Figure 1).
Figure 1.
Flowchart of participants included in the study
Abbreviation: MRI = magnetic resonance imaging; RHR = resting heart rate; MAE = mean absolute error.
Data collection
Participants underwent a comprehensive physical examination and clinical evaluation at baseline. In addition, information on demographic characteristics, socioeconomic status, and lifestyle factors was collected through a computerized touchscreen questionnaire (Method S1, Table S2, and Table S3).
Assessment of RHR
The protocol RHR measurement at the baseline assessment is described in detail in a dedicated document (23). Participants were asked to loosen or remove any restrictive clothing and sit with their feet parallel to each other, toes pointing forward, and soles of the feet resting flat on the floor. RHR was then measured on the participant's left arm (or right arm if the left side was affected by amputation, shunt, mastectomy, or axillary clearance) with the Omron 705 IT electronic blood pressure monitor (OMRON Healthcare Europe B.V. Kruisweg 577 2132 NA Hoofddorp). Two readings were recorded for each participant and the average of the two measurements was used in our analysis. When considered as a categorical variable, RHR was classified as <60, 60–70 (reference), 70–79, and ≥80 beats per minute (bpm) according to previous studies (6, 10).
MRI data acquisition and pre-processing
Details on the UK Biobank brain MRI data acquisition and processing are available on the UK Biobank website in the brain scan protocol and brain imaging documentation (Method S2) (24, 25). Summary measures of imaging-derived phenotypes were generated with an image-processing pipeline developed and run on behalf of the UK Biobank, using publicly available image processing tools FSL (the FMRIB Software Library, version 5.0.10, http://fsl.fmrib.ox.ac.uk/fsl) and FreeSurfer (version 6.0) (26). Finally, 1,079 neuroimaging phenotypes were generated from five modalities, including T1-weighted (n=165), T2-FLAIR (n=1; total volume of white-matter hyperintensities), SWI (n=14), diffusion-MRI (n=675), task fMRI (n=14), and resting-state fMRI (n=210) (Table S4). All MRI phenotypes were Z-transformed before analysis.
Statistical analysis
RHR was operationalized as both a continuous and a categorical variable. Baseline characteristics of the study population by RHR category were analyzed using chi-square tests for categorical variables and one-way ANOVA for continuous variables. Alpha was set at 0.05 for all analyses and results were corrected for multiple comparisons using the false discovery rate (FDR). All statistical analyses were performed using Python (version 3.8.0 with sklearn), Stata SE 16.0 (Stata Corp, College Station, Texas), and R (version 4.1.1).
Assessment of brain age and BAG
Least Absolute Shrinkage and Selection Operator (LASSO) regression was trained in the training dataset. The performance of the model was evaluated using mean absolute error (MAE) on a standardized validation dataset (with mean absolute error =3.232, R2 = 0.690, and Pearson's r = 0.830). Next, the model was used to predict brain age in the entire population (the phenotypes and the corresponding coefficients are list in Table S5). Moreover, we corrected the age bias in brain age prediction as the corrected brain age=(original brain age-β)/α (where coefficients a and β are the slope and intercept of the linear regression model used to estimate the brain age in the training set: brain age_(training set)=α*chronological age_(training set)+β) (27). BAG was defined as corrected brain age minus chronological age. A positive BAG means that the predicted brain age is higher than chronological age (i.e., accelerated aging); a negative BAG means that the predicted brain age is lower (i.e., delayed aging) (21).
Association between RHR and Brain age
Linear regression models were used to estimate the β-coefficients and 95% confidence intervals (CIs) for the association between RHR and brain age or BAG among middle-aged (<60 year) and older (≥60 years) participants. The basic models were adjusted for age, sex, and education. Multivariable-adjusted models were further adjusted for race, socioeconomic status, BMI, alcohol consumption, smoking, physical activity, social contact, hypertension, diabetes, heart disease, medications that reduce RHR (beta blockers and calcium blockers), and apolipoprotein E (APOE) ε4. Stratified analyses were performed to explore the role of CVD in the association of RHR with brain age and BAG. Statistical interaction was examined by creating an indicator variable with the cross-product of two variables.
In sensitivity analysis, we repeated the analyses after 1) stratifying by APOE ε4, physical activity, and polygenic risk score for AD (PRSAD); 2) further adjusting for DASH diet score and PRSAD; and 3) performing multiple imputation for missing values of covariates using Fully Conditional Specification (FCS) method.
Results
Baseline characteristics
The mean age at baseline was 54.74 ± 7.49, and 53.44% of participants were female. Of the participants, the mean RHR was 67.79 ± 10.43 bpm. Compared to participants with lower RHR, those with higher RHR were more likely to be older and female; to have, BMI and social contact, lower education level, socioeconomic status (SES), and physical activity; and to be non-drinkers and current smokers. In addition, they tended to have a history of hypertension, diabetes, and heart disease, and higher usage of calcium channel blockers but lower usage of beta-blockers (Table 1).
Table 1.
Baseline characteristics of the study populations by resting heart rate (RHR) group (n= 33,381)
| Characteristics | RHR (bpm) | P value | |||
|---|---|---|---|---|---|
| <60 (n = 7,341, 22.0%) | 60–69 (n = 12,948, 38.8%) | 70–79 (n = 9,012, 27.0%) | ≥ 80(n = 4,089, 12.2%) | ||
| Age (y) | 55.06 (7.45) | 54.74 (7.44) | 54.54 (7.58) | 54.78 (7.54) | <0.001 |
| Female | 2,996 (40.81) | 7,137 (55.12) | 5,368 (59.57) | 2,321 (56.89) | <0.001 |
| Race-White | 6,821 (93.16) | 11,965 (92.63) | 8,326 (92.64) | 3,774 (92.80) | 0.526 |
| Townsend deprivation index | −2.72 (−3.95, −0.75) | −2.63 (−3.90, −0.57) | −2.55 (−3.85, −0.38) | −2.47 (−3.79, −0.14) | <0.001 |
| Education (college) | 3,506 (48.43) | 5,942 (46.60) | 4,082 (46.03) | 1,818 (45.47) | 0.005 |
| BMI (kg/m2) | 25.77 (3.60) | 26.22 (3.93) | 26.83 (4.33) | 27.82 (4.95) | <0.001 |
| Alcohol consumption status | <0.001 | ||||
| Never | 117 (1.59) | 284 (2.19) | 248 (2.75) | 132 (3.24) | |
| Former drinker | 132 (1.80) | 253 (1.95) | 170 (1.89) | 111 (2.72) | |
| Current drinker | 7,088 (96.61) | 12,405 (95.85) | 8,591 (95.36) | 3,834 (94.04) | |
| Smoking status | <0.001 | ||||
| Never | 4,377 (59.76) | 7,879 (60.99) | 5,567 (61.91) | 2,538 (62.30) | |
| Former smoker | 2,541 (34.69) | 4,333 (33.54) | 2,849 (31.68) | 1,203 (29.53) | |
| Current smoker | 406 (5.54) | 706 (5.47) | 576 (6.41) | 333 (8.17) | |
| Regular physical activity | 4,563 (62.95) | 7,771 (60.93) | 5,258 (59.30) | 2,366 (59.25) | <0.001 |
| Regular social contact | 2686 (37.05) | 4983 (39.07) | 3609 (40.70) | 1627 (40.75) | <0.001 |
| Hypertension | 3,101 (42.24) | 5,267 (40.68) | 4,094 (45.43) | 2,333 (57.18) | <0.001 |
| Diabetes | 134 (1.83) | 271 (2.09) | 244 (2.71) | 225 (5.51) | <0.001 |
| Heart disease | 486 (6.62) | 367 (2.83) | 236 (2.62) | 126 (3.09) | <0.001 |
| Medication | |||||
| Beta-blockers | 673 (9.17) | 366 (2.83) | 146 (1.62) | 44 (3.58) | <0.001 |
| Calcium blockers | 205 (2.79) | 396 (3.06) | 318 (3.53) | 205 (5.02) | <0.001 |
| APOE e4 carrier | 1,769 (28.69) | 2,972 (27.31) | 2,057 (27.32) | 900 (26.97) | 0.165 |
| Brain age | 63.36 (6.13) | 63.36 (6.06) | 63.49 (6.31) | 64.09 (6.35) | <0.001 |
| Brain age gap | 0.01 (4.90) | 0.28 (4.94) | 0.62 (5.32) | 1.28 (5.30) | <0.001 |
Abbreviations: APOE ε4 = apolipoprotein E epsilon; BMI = body mass index; PRSAD = polygenetic risk score of Alzheimer's disease. Missing data: Race = 88; Education = 524; BMI = 30; Townsend deprivation index = 31; Alcohol consumption = 16; Smoking = 73; Regular social contact = 518; Regular physical activity = 1,101; APOE ε4 carrier = 5468.
Association of resting heart rate with brain age and BAG
Among all participants, the time interval between study entry and MRI assessment was 8.94 ± 1.78 years. Higher RHR was associated with older brain age (β for per 1-SD increase: 0.331, 95% CI: 0.265, 0.398) and larger BAG (β: 0.263, 95% CI: 0.202, 0.324) when RHR was analyzed as a continuous variable (Table 2). Furthermore, when RHR was categorized, RHR 70–79 bpm and RHR ≥80 bpm were related to older brain age (β [95% CI]: 0.361 [0.196, 0.526] / 0.737 [0.517, 0.957]) and larger BAG (β [95% CI]: 0.256 [0.105, 0.407] / 0.638 [0.436, 0.839]) compared to RHR 60–69 bpm (Table 2). In addition, RHR <60 bpm was associated with younger brain age (β: −0.324, 95% CI: −0.500, −0.147) and smaller BAG (β: −0.230, 95% CI: −0.392, −0.067). The results of basic-adjusted models were similar to the multi-adjusted models (Table 2). Regression coefficients for the covariates in relation to brain volumes were shown in Supplementary Table 7.
Table 2.
The association of resting heart rate (RHR) with brain age and brain age gap (BAG)
| RHR | Brain age | BAG | ||
|---|---|---|---|---|
| β (95% CI) * | β (95% CI) † | β (95% CI) † | β (95% CI) † | |
| All participants (N = 33,381) | ||||
| Continuous (per 1-SD increase) Categories | 0.432 (0.375, 0.489) ‡ | 0.331 (0.265, 0.398) ™ | 0.399 (0.346, 0.452) ‡ | 0.263 (0.202, 0.324) † |
| < 60 bpm | −0.355 (−0.515, −0.196) ‡ | −0.324 (−0.500, −0.147) ‡ | −0.311 (−0.458, −0.164) ‡ | −0.230 (−0.392, −0.067) † |
| 60–69 bpm | Reference | Reference | Reference | Reference |
| 70–79 bpm | 0.411 (0.262, 0.561) ‡ | 0.361 (0.196, 0.526) ‡ | 0.346 (0.209, 0.484) ‡ | 0.256 (0.105, 0.407) † |
| ≥ 80 bpm | 1.069 (0.873, 1.265) ‡ | 0.737 (0.517, 0.957) ‡ | 1.033 (0.853, 1.213) ‡ | 0.638 (0.436, 0.839) † |
| Middle-aged (40–60 years, n = 22,923) | ||||
| Continuous (per 1-SD increase) Categories | 0.412 (0.345, 0.480) ‡ | 0.271 (0.194, 0.348) ‡ | 0.386 (0.324, 0.449) ‡ | 0.201 (0.130, 0.272) † |
| < 60 bpm | −0.405 (−0.592, −0.218) ‡ | −0.270 (−0.475, −0.066) ‡ | −0.388 (−0.561, −0.216) ‡ | −0.196 (−0.384, −0.007) |
| 60–69 bpm | Reference | Reference | Reference | Reference |
| 70–79 bpm | 0.361 (0.189, 0.534) ‡ | 0.322 (0.133, 0.511) ‡ | 0.307 (0.147, 0.467) ‡ | 0.222 (0.048, 0.396) † |
| ≥ 80 bpm | 0.973 (0.745, 1.201) ‡ | 0.604 (0.349, 0.858) ‡ | 0.920 (0.709, 1.131) ‡ | 0.461 (0.226, 0.695) † |
| Older-aged (60+ years, n = 10,458) | ||||
| Continuous (per 1-SD increase) Categories | 0.457 (0.349, 0.566) ‡ | 0.438 (0.310, 0.565) ‡ | 0.411 (0.312, 0.510) ‡ | 0.375 (0.258, 0.491) † |
| < 60 bpm | −0.255 (−0.558, 0.048) | −0.431 (−0.774, −0.089) | −0.153 (−0.429, 0.123) | −0.298 (−0.610, 0.014) |
| 60–69 bpm | Reference | Reference | Reference | Reference |
| 70–79 bpm | 0.485 (0.195, 0.774) ‡ | 0.399 (0.074, 0.724) ‡ | 0.398 (0.133, 0.662) ‡ | 0.281 (-0.014, 0.576) |
| ≥ 80 bpm | 1.239 (0.866, 1.612) ‡ | 0.974 (0.549, 1.400) ‡ | 1.237 (0.898, 1.577) ‡ | 0.972 (0.585, 1.359) † |
| P-interaction | <0.001† | 0.031 † | ||
* Model adjusted for age, sex, and education. † Model adjusted for age, sex, education, race, Socioeconomic status, body mass index, alcohol consumption, smoking, physical activity, social contact, hypertension, diabetes, heart disease, beta-blockers, calcium blockers, and APOE ε4. 1 FDR P <0.05.
In age-stratified analyses, the association of RHR ≥80 bpm with older brain age and larger BAG was strongest among middle-aged participants, but was also present among older participants (Table 2). In contrast, the association between RHR <60 bpm and younger brain age and smaller BAG was only significant among middle-aged participants (Table 2). There was a significant multiplicative interaction between RHR and age group for brain age and BAG (P-interaction= 0.001 and 0.031).
Role of CVD
In CVD-stratified analyses (Figure 2 and Table S6), RHR ≥80 bpm was associated with older brain age and larger BAG compared to RHR 60–69 bpm among both CVD and CVD-free participants, regardless of age group. However, the association between RHR 70–79 bpm and older brain age was only present in participants with CVD. There was no statistical interaction between RHR and CVD on brain age or BAG in the multi-variable adjusted models (all P-interactions>0.05).
Figure 2.
Association of RHR with brain age and BAG: stratified by CVD
The figure represents the association between RHR (reference: 60–69 bpm) and brain age and BAG among CVD and CVD-free participants: (A/B) RHR-brain age/BAG association among middle-aged adults; (C/D) RHR-brain age/BAG association among older-aged adults. Model adjusted for age, sex, education, race, Socioeconomic status, body mass index, alcohol consumption, smoking, physical activity, social contact, diabetes, beta-blockers, calcium blockers, and APOE ε4. The height of each bar in the plot represents the point estimate of β, while the error bars represent the 95% confidence intervals of β. * FDR P< 0.05.
Supplementary analysis
Largely similar results were obtained after we conducted the following sensitivity analyses: 1) stratifying by APOE ε4 (Table S8), physical activity level (Table S9), and PRSAD (Table S10); 2) further adjusting for DASH diet score and PRSAD (Table S11 and S12); and 3) performing multiple imputation for missing values of covariates (Table S13).
Discussion
In this large neuroimaging study with multimodal MRI measures, we constructed a brain age prediction model based on LASSO regression and found that 1) RHR 70–79 bpm and RHR≥80 bpm was associated with older brain age and larger BAG among both middle-aged and older adults; 2) RHR <60 bpm was associated with younger brain age and smaller BAG only among middle-aged participants; and 3) the association of RHR 70–79 with older brain age was only present among people with CVDs.
RHR and brain aging
Several previous studies have linked RHR to individual MRI measures (7, 8, 14, 15, 16, 17, 18). Some studies have reported associations between elevated RHR and more severe brain lesions including white matter hyperintensity (8, 14, 16), brain infarction (16), and ischemic lesions (8), while others related higher RHR to smaller brain volumes including total brain (17) and some subfields of the hippocampus (7), but with some inconsistent findings (8). Limited studies evaluated the association between elevated RHR and poor brain functional connectivity (15, 18). However, these studies offer limited support for the association between RHR and brain aging as they solely examined separate MRI metrics that may not adequately capture the extent of brain aging in individuals. By ‘learning' the correspondence between patterns in structural or functional multimodal neuroimaging data and an age ‘label', machine-learning algorithms can formulate massively high-dimensional regression models, fitting large neuroimaging datasets as independent variables to predict chronological age as the dependent variable. Predicted brain age and derived BAG provide a more comprehensive description of brain aging (20). In the present study, we found that elevated RHR was associated with unhealthy brain aging, including older brain age and larger BAG. Our findings provide further evidence that elevated RHR may play a role in the process of brain aging. Further, after stratification by age, the association of elevated RHR with older brain age and larger BAG remains significant among middle-aged and older adults. These results add a growing body of evidence that the effect of RHR on brain aging may begin as early as middle age. To our knowledge, this is the first study to address the association of RHR with brain age and BAG, supported by multimodal brain MRI data.
Role of CVD in RHR-brain age association
RHR is a strong predictor of cardiovascular events including hypertension, myocardial infarction, angina, congestive heart failure, and atrial fibrillation (28, 29). Moreover, these non-stroke CVDs are associated with brain aging (30, 31, 32). However, to date, the comprehensive differences in the RHR-brain aging association across different CVD states have not been well known. In the current study, we found that the association between RHR ≥80 bpm and brain aging was present not only in the CVD population but also in the non-CVD population, with no significant interaction between RHR and CVD on brain aging. Our findings suggest that monitoring RHR is beneficial for indicating brain aging among individuals both with and without CVD.
Potential mechanisms underlying RHR-brain age association
There are several mechanisms whereby elevated RHR may link to brain aging. First, increased RHR may lead to decreased cerebral blood flow, aggravating ischemia or white matter lesions, and lacunar infarction in some brain regions (33, 34). In addition, high RHR can lead to cerebral hypoxia, which causes vascular endothelial dysfunction and enhanced coagulation activity, bringing vascular and neurodegenerative damage in the brain (35, 36). Second, elevated RHR may also be a marker of autonomic dysfunction, which may drive the development of cognitive decline and dementia by activating inflammatory pathways and increasing the levels of inflammatory markers such as hs-CRP, IL-6, and fibrinogen (37, 38). Third, brain aging and CVDs may share similar pathogenic processes (39, 40). However, the association of elevated RHR with older brain age and larger BAG remained significant among CVD-free people and after controlling for traditional cardiovascular risk factors, which may indicate an independent effect of RHR on brain aging. Future studies are warranted to better understand the mechanisms underlying the influence of RHR on brain health.
Strength and limitations
Strengths of this study include the large-scale community-based design with a comprehensive data collection procedure. Additionally, the UK Biobank provides image-derived phenotypes of various brain measures, offering an opportunity to calculate multimodal brain age using machine learning models. Nonetheless, some limitations should be acknowledged. First, the UK Biobank participants were volunteers and generally healthier and more highly educated than the general population (41). We noted that all participants who underwent MRI scans had high economic status, and the differences in SES between the different RHR groups may be due to the large sample. Moreover, our analytical sample consisted of participants who underwent brain MRI scans and were free from chronic brain disorders, which is a relatively healthier subset in the overall UK Biobank population. This might have contributed to a misestimating of the magnitude of the association between elevated RHR and brain aging. Furthermore, our findings may only be generalizable to demographically similar cohorts, and this limitation precludes the generalization of these findings to the general population. Second, although the direction of the associations of RHR with brain age and BAG may indicate the potential effect of RHR itself on brain aging, these results cannot draw causal inferences. However, a subgroup of approximately 10,000 participants from UKB is currently undergoing repeat brain MRI scans (42), providing an opportunity for future studies to explore the longitudinal association between RHR and brain aging. Third, selection bias might have occurred due to missing data. However, the results were not much altered after repeating the analysis using multiple imputations for missing variables.
Conclusion
In conclusion, our study provides new evidence that elevated RHR may associated with brain aging across middle- and older-age and decreased RHR (<60 bpm) was related to younger brain age among middle-aged adults. CVD may play a role in the association of RHR 70–79 bpm with older brain age and larger BAG. The RHR is a very commonly used parameter in clinical settings and can be obtained more easily and quickly than complex cognitive assessments. Moreover, there are a number of drugs (such as beta-blockers) that can be used to control RHR, and if a longitudinal or causal association between RHR and brain aging can be identified, it may open up new possibilities for intervention and treatment of cognitive impairment and dementia. Thus, future longitudinal studies or Mendelian randomization are needed to explore the longitudinal effects of RHR on brain aging.
Acknowledgments
The authors thank all participants of the UK Biobank study who have dedicated their valuable time toward this project and the UK Biobank team for collecting, preparing, and providing data used in this work. The research has been done using the UK Biobank resource as a part of the approved Research Application 67048.
Footnotes
Contributed equally as first authors.
Contributor Information
Xiangyu Ma, Email: xymacq@tmmu.edu.cn.
Weili Xu, Email: weili.xu@ki.se.
Supplementary methods
Supplementary material is available in the online version of this article at https://doi.org/10.14283/jpad.2024.76.
Supplementary material, approximately 28 KB.
Supplementary material, approximately 152 KB.
Author Contribution: W.X. and J.W. contributed to the conception and design of the study. J.W. conducted the statistical analyses with support from H.H., performed the literature search, and drafted the manuscript. H.H., W.Y., A.D., X.M., and W.X. reviewed and edited the manuscript. All authors critically revised the manuscript for important intellectual content. All authors made a significant contribution to finalizing the manuscript and approved the final version for publication.
Funding: Weili Xu received grants from the Swedish Research Council (No. 2021-01647), the Swedish Council for Health Working Life and Welfare (2021-01826), the Lindhés Advokatbyrå AB (2021-0134), and Stiftelsen för Gamla Tjänarinnor (2021-2022). Xiangyu Ma received grants from Chongqing Talents: Exceptional Young Talents Project (CQYC202005003), the National Natural Science Foundation of China (82373643), and the Outstanding Youth Science Fund of Chongqing (cstc2020jcyjjqX0014). The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; in the preparation of the manuscript; or in the review or approval of the manuscript. Open access funding provided by Karolinska Institute.
Data Availability: The datasets generated and analysed during the current study are available in the UK Biobank repository, http://www.ukbiobank.ac.uk.
Competing interests: The authors declare that they have no competing interests.
Ethical Standards: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
References
- 1.Zhang GQ, Zhang W. Heart rate, lifespan, and mortality risk. Ageing Res Rev. 2009;8(1):52–60. doi: 10.1016/j.arr.2008.10.001. 10.1016/j.arr.2008.10.001 PubMed PMID: 19022405. [DOI] [PubMed] [Google Scholar]
- 2.Moghtadaei M, Jansen HJ, Mackasey M, et al. The impacts of age and frailty on heart rate and sinoatrial node function. J Physiol. 2016;594(23):7105–7126. doi: 10.1113/JP272979. 10.1113/JP272979 PubMed PMID: 27598221; PMCID 5134407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kaplan DT, Furman MI, Pincus SM, Ryan SM, Lipsitz LA, Goldberger AL. Aging and the complexity of cardiovascular dynamics. Biophys J. 1991;59(4):945–949. doi: 10.1016/S0006-3495(91)82309-8. 10.1016/S0006-3495(91)82309-8 PubMed PMID: 2065195; PMCID 1281262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hotta H, Uchida S. Aging of the autonomic nervous system and possible improvements in autonomic activity using somatic afferent stimulation. Geriatr Gerontol Int. 2010;10(Suppl 1):S127–S136. doi: 10.1111/j.1447-0594.2010.00592.x. PubMed PMID: 20590828. [DOI] [PubMed] [Google Scholar]
- 5.Aune D, Sen A, ó'Hartaigh B, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2017;27(6):504–517. doi: 10.1016/j.numecd.2017.04.004. 10.1016/j.numecd.2017.04.004 PubMed PMID: 28552551. [DOI] [PubMed] [Google Scholar]
- 6.Imahori Y, Vetrano DL, Xia X, et al. Association of resting heart rate with cognitive decline and dementia in older adults: A population-based cohort study. Alzheimers Dement. 2021 doi: 10.1002/alz.12495. [DOI] [PubMed] [Google Scholar]
- 7.Deng YT, Kuo K, Wu BS, et al. Associations of resting heart rate with incident dementia, cognition, and brain structure: a prospective cohort study of UK biobank. Alzheimers Res Ther. 2022;14(1):147. doi: 10.1186/s13195-022-01088-3. 10.1186/s13195-022-01088-3 PubMed PMID: 36199126; PMCID 9535982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Haring B, Liu J, Rapp SR, et al. Heart Rate, Brain Imaging Biomarkers and Cognitive Impairment in Older (≥63 years) Women. Am J Cardiol. 2020;129:102–108. doi: 10.1016/j.amjcard.2020.05.030. 10.1016/j.amjcard.2020.05.030 PubMed PMID: 32576368; PMCID 9879294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Böhm M, Cotton D, Foster L, et al. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J. 2012;33(22):2804–2812. doi: 10.1093/eurheartj/ehs250. 10.1093/eurheartj/ehs250 PubMed PMID: 22922507. [DOI] [PubMed] [Google Scholar]
- 10.Wang S, Fashanu OE, Zhao D, et al. Relation of Elevated Resting Heart Rate in Mid-Life to Cognitive Decline Over 20 Years (from the Atherosclerosis Risk in Communities [ARIC] Study) Am J Cardiol. 2019;123(2):334–340. doi: 10.1016/j.amjcard.2018.10.013. 10.1016/j.amjcard.2018.10.013 PubMed PMID: 30424869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Böhm M, Schumacher H, Leong D, et al. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk. Hypertension. 2015;65(3):651–661. doi: 10.1161/HYPERTENSIONAHA.114.04568. 10.1161/HYPERTENSIONAHA.114.04568 PubMed PMID: 25583157. [DOI] [PubMed] [Google Scholar]
- 12.Zheng Y, Guo H, Zhang L, Wu J, Li Q, Lv FJFiN. Machine learning-based framework for differential diagnosis between vascular dementia and Alzheimer's disease using structural MRI features. 2019:1097. [DOI] [PMC free article] [PubMed]
- 13.Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PMJNRN. The clinical use of structural MRI in Alzheimer disease. 2010;6(2):67–77. doi: 10.1038/nrneurol.2009.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Leung LY, Bartz TM, Rice K, et al. Blood Pressure and Heart Rate Measures Associated With Increased Risk of Covert Brain Infarction and Worsening Leukoaraiosis in Older Adults. Arterioscler Thromb Vasc Biol. 2017;37(8):1579–1586. doi: 10.1161/ATVBAHA.117.309298. 10.1161/ATVBAHA.117.309298 PubMed PMID: 28663254; PMCID 5551454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yoshikawa A, Masaoka Y, Yoshida M, et al. Heart Rate and Respiration Affect the Functional Connectivity of Default Mode Network in Resting-State Functional Magnetic Resonance Imaging. Front Neurosci. 2020;14:631. doi: 10.3389/fnins.2020.00631. 10.3389/fnins.2020.00631 PubMed PMID: 32694974; PMCID 7338607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Nakanishi K, Jin Z, Homma S, et al. Association Between Heart Rate and Subclinical Cerebrovascular Disease in the Elderly. Stroke. 2018;49(2):319–324. doi: 10.1161/STROKEAHA.117.019355. 10.1161/STROKEAHA.117.019355 PubMed PMID: 29284731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Spartano NL, Himali JJ, Beiser AS, et al. Midlife exercise blood pressure, heart rate, and fitness relate to brain volume 2 decades later. Neurology. 2016;86(14):1313–1319. doi: 10.1212/WNL.0000000000002415. 10.1212/WNL.0000000000002415 PubMed PMID: 26865519; PMCID 4826343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.de la Cruz F, Schumann A, Köhler S, Reichenbach JR, Wagner G, Bär KJ. The relationship between heart rate and functional connectivity of brain regions involved in autonomic control. Neuroimage. 2019;196:318–328. doi: 10.1016/j.neuroimage.2019.04.014. 10.1016/j.neuroimage.2019.04.014 PubMed PMID: 30981856. [DOI] [PubMed] [Google Scholar]
- 19.Franke K, Gaser C. Ten Years of BrainAGE as a Neuroimaging Biomarker of Brain Aging: What Insights Have We Gained? Frontiers in Neurology. 2019;10:789. doi: 10.3389/fneur.2019.00789. 10.3389/fneur.2019.00789 PubMed PMID: 31474922; PMCID 6702897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bzdok D. Classical Statistics and Statistical Learning in Imaging Neuroscience. Front Neurosci. 2017;11:543. doi: 10.3389/fnins.2017.00543. 10.3389/fnins.2017.00543 PubMed PMID: 29056896; PMCID 5635056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Baecker L, Garcia-Dias R, Vieira S, Scarpazza C, Mechelli A. Machine learning for brain age prediction: Introduction to methods and clinical applications. EBioMedicine. 2021;72 doi: 10.1016/j.ebiom.2021.103600. 10.1016/j.ebiom.2021.103600 PubMed PMID: 34614461; PMCID 8498228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3) doi: 10.1371/journal.pmed.1001779. 10.1371/journal.pmed.1001779 PubMed PMID: 25826379; PMCID 4380465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.UK Biobank Blood Pressure. https://biobank.ndph.ox.ac.uk/showcase/showcase/docs/Bloodpressure.pdf
- 24.Miller KL, Alfaro-Almagro F, Bangerter NK, et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci. 2016;19(11):1523–1536. doi: 10.1038/nn.4393. 10.1038/nn.4393 PubMed PMID: 27643430; PMCID 5086094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Smith S, Almagro FA, Miller K. UK Biobank Brain Imaging Documentation. https://biobank.ndph.ox.ac.uk/showcase/ukb/docs/brain__mri.pdf
- 26.Alfaro-Almagro F, Jenkinson M, Bangerter NK, et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. Neuroimage. 2018;166:400–424. doi: 10.1016/j.neuroimage.2017.10.034. 10.1016/j.neuroimage.2017.10.034 PubMed PMID: 29079522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cole JH, Ritchie SJ, Bastin ME, et al. Brain age predicts mortality. Molecular Psychiatry. 2018;23(5):1385–1392. doi: 10.1038/mp.2017.62. 10.1038/mp.2017.62 PubMed PMID: 28439103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50(9):823–830. doi: 10.1016/j.jacc.2007.04.079. 10.1016/j.jacc.2007.04.079 PubMed PMID: 17719466. [DOI] [PubMed] [Google Scholar]
- 29.Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med. 2015;128(3):219–228. doi: 10.1016/j.amjmed.2014.09.016. 10.1016/j.amjmed.2014.09.016 PubMed PMID: 25447617. [DOI] [PubMed] [Google Scholar]
- 30.Newman AB, Fitzpatrick AL, Lopez O, et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005;53(7):1101–1107. doi: 10.1111/j.1532-5415.2005.53360.x. 10.1111/j.1532-5415.2005.53360.x PubMed PMID: 16108925. [DOI] [PubMed] [Google Scholar]
- 31.Stefanidis KB, Askew CD, Greaves K, Summers MJ. The Effect of Non-Stroke Cardiovascular Disease States on Risk for Cognitive Decline and Dementia: A Systematic and Meta-Analytic Review. Neuropsychol Rev. 2018;28(1):1–15. doi: 10.1007/s11065-017-9359-z. 10.1007/s11065-017-9359-z PubMed PMID: 28856507. [DOI] [PubMed] [Google Scholar]
- 32.Shang X, Zhang X, Huang Y, et al. Association of a wide range of individual chronic diseases and their multimorbidity with brain volumes in the UK Biobank: A cross-sectional study. EClinicalMedicine. 2022;47 doi: 10.1016/j.eclinm.2022.101413. 10.1016/j.eclinm.2022.101413 PubMed PMID: 35518119; PMCID 9065617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Ajmani RS, Metter EJ, Jaykumar R, et al. Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function. Neurobiol Aging. 2000;21(2):257–269. doi: 10.1016/s0197-4580(00)00118-4. 10.1016/S0197-4580(00)00118-4 PubMed PMID: 10867210. [DOI] [PubMed] [Google Scholar]
- 34.Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004;5(5):347–360. doi: 10.1038/nrn1387. 10.1038/nrn1387 PubMed PMID: 15100718. [DOI] [PubMed] [Google Scholar]
- 35.Cohen AD. Distinct pathways for cognitive decline in the presence of Alzheimer's disease pathology or cerebrovascular disease. Brain. 2016;139:2340–2341. doi: 10.1093/brain/aww183. 10.1093/brain/aww183 PubMed PMID: 27559107; Pt 9. [DOI] [PubMed] [Google Scholar]
- 36.Stauton M, Drexler C, Dulitz MG, Ekbom DC, Schmeling WT, Farber NE. Effects of hypoxia-reoxygenation on microvascular endothelial function in the rat hippocampal slice. Anesthesiology. 1999;91(5):1462–1469. doi: 10.1097/00000542-199911000-00040. 10.1097/00000542-199911000-00040 PubMed PMID: 10551599. [DOI] [PubMed] [Google Scholar]
- 37.Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med. 2007;13(3–4):178–184. doi: 10.2119/2006-00112.Sloan. 10.2119/2006-00112.Sloan PubMed PMID: 17592552; PMCID 1892756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J. 2004;25(5):363–370. doi: 10.1016/j.ehj.2003.12.003. 10.1016/j.ehj.2003.12.003 PubMed PMID: 15033247. [DOI] [PubMed] [Google Scholar]
- 39.Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet. 1999;354(9182):919–920. doi: 10.1016/S0140-6736(99)02355-7. 10.1016/S0140-6736(99)02355-7 PubMed PMID: 10489957. [DOI] [PubMed] [Google Scholar]
- 40.Decarli C. Vascular factors in dementia: an overview. J Neurol Sci. 2004;226(1–2):19–23. doi: 10.1016/j.jns.2004.09.005. 10.1016/j.jns.2004.09.005 PubMed PMID: 15537513. [DOI] [PubMed] [Google Scholar]
- 41.Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186(9):1026–1034. doi: 10.1093/aje/kwx246. 10.1093/aje/kwx246 PubMed PMID: 28641372; PMCID 5860371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Littlejohns TJ, Holliday J, Gibson LM, et al. The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions. Nature Communications. 2020;11(1) doi: 10.1038/s41467-020-15948-9. 10.1038/s41467-020-15948-9 PubMed PMID: 32457287; PMCID 7250878. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary material, approximately 28 KB.
Supplementary material, approximately 152 KB.